According to the latest research, GSDME inhibits EGFR signaling pathway and promotes non-small-cell lung cancer (NSCLC) cells’ survival by enhancing EGFR dimerization and activation [107]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.